Late-life depression was associated with a significant increase in ICAM-1 in the deep white matter of the dorsolateral prefrontal cortex compared to controls (p=0.01).
Case-Control (n=40)
Blindly rated
Is there neuropathological evidence of ischemia (ICAM-1 and VCAM-1) in the white matter of the dorsolateral prefrontal cortex in elderly patients with late-life depression compared to controls?
The study provides neuropathological evidence of white matter ischemia in the dorsolateral prefrontal cortex of elderly patients with depression, supporting the 'vascular depression' hypothesis.
p-value: p=0.01
BACKGROUND: Signal hyperintensities on magnetic resonance imaging in late-life depression are associated with treatment resistance and poor outcome. These lesions are probably vascular in origin and proposed sites for vascular damage include the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC). METHODS: We therefore examined white matter in these areas for microvascular disease and evidence of ischemia using intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1). We obtained postmortem tissue from elderly depressed (n = 20) and control (n = 20) subjects and blindly rated microvascular disease and ICAM-1 and VCAM-1 amount using quantitative image analysis in sections of the DLPFC, ACC and occipital cortex (OC; control area). RESULTS: We found a significant increase in ICAM-1 in the deep white matter of the DLPFC in the depressed group (p = 0.01) and a trend towards an increase for VCAM-1 (p = 0.10). In the gyral white matter there was a trend towards significance for both molecules (p = 0.07 and 0.10). No differences were found in the ACC or OC or for microvascular disease in any area. CONCLUSIONS: These findings are consistent with white matter ischemia in the DLPFC and lend support to the 'vascular depression' hypothesis. They implicate the DLPFC as an important site in the pathogenesis of late-life depression and have major implications for the understanding and management of late-life depression and raise the possibility of novel treatments being introduced in the future.
Thomas et al. (Wed,) conducted a case-control in Late-life depression (n=40). Late-life depression vs. Control subjects was evaluated on Microvascular disease and evidence of ischemia using ICAM-1 and VCAM-1 in the DLPFC, ACC, and OC (p=0.01). Late-life depression was associated with a significant increase in ICAM-1 in the deep white matter of the dorsolateral prefrontal cortex compared to controls (p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: